Vol 2 Chapter 2064: The billion-scale market on hair

Regarding the application of hair follicle cloning and transplantation treatment technology, Wu Hao and the others have also drawn up a very complete implementation plan. The ultimate goal is to bring this technology to the market within two to three years.
And from this summer to fall, this technology will also be officially launched for clinical trials, and sixty to one hundred patients will be recruited for Phase I clinical trials at the initial stage. After the first phase clinical trial achieves the desired results, the second phase clinical trial will be carried out immediately, and 300 to 500 patients will be recruited for further clinical trials.
When the results of the Phase II clinical trial reach the expected goal, they will immediately enter the Phase III clinical trial.
The more people involved in a clinical trial, the richer and more accurate the data collected. Wu Hao and the others certainly hope that the more data in this area, the better, or that is what all pharmaceutical manufacturers think.
However, the cost of clinical trials is huge, so everyone tends to control them within a reasonable range. As long as the drug or treatment technology developed meets the relevant expected standards, the clinical trial can end.
Generally speaking, you can apply for marketing after the Phase III clinical trial is completed. However, some drugs and technologies are still being researched after they are listed, and there may even be Phase IV and Phase V clinical trials.
On the one hand, its purpose is of course to conduct more detailed experiments on this drug or technical achievements, so as to obtain more data information, such as what kind of effect this drug has on what diseases, and what side effects does it have for ordinary people and specific groups of people. Wait, these all take a long time to research.
Therefore, you may find that some expensive drugs or some common drugs have very detailed instructions, and a lot of them are densely written, all of which are related research information about this drug.
On the other hand, it is to dig out the maximum value of this drug and technology. For example, the development of some drugs is usually dramatic. For example, the well-known aphrodisiac drug, Brother W, was originally developed to treat heart disease and cardiovascular disease. However, researchers later found that the drug has great side effects, and one of the most important side effects is that it is easy to cause men to stand up.
As a result, this drug, which was originally used to treat new elders and cardiovascular diseases, has dramatically become a holy medicine for men to regain their majesty, but its original role has been gradually ignored by people.
There are also some drugs that have very good therapeutic effects on different diseases, that is to say, one drug can cure many diseases. And in this way, the drug is used more widely, the demand will increase exponentially, and its market revenue will naturally rise.
Especially for many pharmaceutical companies, it is not easy to develop a new drug, the investment is huge, and it is time-consuming and labor-intensive. Basically, it takes five to ten years to produce results, and it may not be successful.
So now that a drug has been made, these pharmaceutical companies naturally want to tap the full value of the drug.
As far as this hair follicle cloning and transplantation treatment technology is concerned, its market prospect is definitely very broad. Wu Hao and the others once estimated that once this technology is put into commercial use, it will bring more than 100 billion market benefits to Haoyu Technology.
This is definitely a huge market, after all, for all the men and women who are suffering from hair loss or have lost their heads, regaining their beautiful black hair is the dream of these people.
"Can this price really be controlled so low? In theory, it seems to be much more complicated than ordinary hair transplant techniques." An expert who was also present with some hair loss asked.
Hearing the expert's words, everyone present nodded and looked at Wu Hao. Indeed, they also have such questions in their minds. In the case of this kind of hair follicle, the cloning cultivation and transplantation treatment technology should be more complicated, why is it cheaper than ordinary hair transplantation.
Facing the curious eyes of everyone, Wu Hao said with a smile: "First of all, traditional hair transplant surgery is to collect and extract hair follicles from other parts of the patient. This process is relatively slow, and then the extracted hair follicles must be extracted. Sort out and remove some of the unqualified ones.
Finally, these extracted hair follicles are planted little by little into the part of the patient's head that needs to be covered up. The entire treatment process is basically manual, which is very time-consuming and labor-intensive, so the cost is naturally large.
As for our technology, it uses automated and intelligent medical technology to a large extent. For example, some processes can be carried out autonomously through these surgical instruments. Not only the operation time is shorter, the efficiency is faster, and the average quality is better than manual operation. The implantation is more stable, which increases the guarantee of the survival rate of the hair transplant.
And it is also because of the addition of automated and unmanned surgical instruments, which greatly liberates the hands of doctors. In this way, the corresponding treatment costs will be greatly reduced. "
Hearing Wu Hao's introduction, everyone immediately laughed, but the smiles on the faces of the medical experts present were more or less bitter. Hearing that Wu Hao wanted to replace the original hair transplants and carry out hair transplants on their behalf, this was undoubtedly robbing them of their jobs. As peers, how can they bear it, and at the same time they have a great sense of crisis for their professional work.
This sense of crisis did not appear at this time, in fact, it has appeared long ago. In particular, Wu Hao and the others came up with 3D bioprinting technology, which made Xu Shenghua, Zhang Qinghong and other experts feel a little bit of a sense of crisis in their hearts. The medical technology experience they used to rely on for survival seems to be so vulnerable in the face of new technology.
And this time, I saw the recovery changes on the patient's face, which made their sense of crisis even stronger. Maybe one day, they really don't need them, and there are machines and equipment.
You mean that the entire hair transplant process uses intelligent medical devices, and does not require the participation of doctors. Wu Jiuzhi grasped the core of the problem and watched Wu Hao ask for proof.
Wu Hao smiled and nodded: "Actually, not only the hair transplant process, but also the cloning and cultivation process of these hair follicle tissues can be completely handed over to robots.
We only need to feed the patient's hair follicle tissue samples into the machine equipment, and the relevant cloning equipment will clone the hair follicle tissue and then cultivate it. After the required number of cloned breeding materials are cultivated, the bio-3D printing equipment will work autonomously, thereby printing out batches of cloned hair follicles. "